Stocks
G1 Therapeutics (GTHX) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 9 969% | 3 277% | 16 466% | ||||||
| Changes by years, y/y, % | -8 357pp | -6 692pp | -3 277pp | -2.1% | |||||
G1 Therapeutics. R&D/CAPEX, %
G1 Therapeutics. R&D/CAPEX, changes, pp
G1 Therapeutics (GTHX) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| R&D/CAPEX, % | 4 119% | |||||||
| Changes by years, y/y, % | ||||||||
| Changes by quarters, q/q, % | ||||||||
